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Background:  Mycobacterium tuberculosis (Mtb) heparin 
binding hemagglutinin (HBHA) is an Ag known to evoke ef-
fective host immune responses during tuberculosis infection. 
However, the molecular basis of the host immune response 
to HBHA has not been fully characterized. In this study, we 
examined the molecular mechanisms by which HBHA can in-
duce the expression of proinflammatory cytokines in 
macrophages. Methods: HBHA-induced mRNA and protein 
levels of proinflammatory cytokines were determined in bone 
marrow-derived macrophages (BMDMs) using RT-PCR and 
ELISA analysis. The roles of intracellular signaling pathways 
for NF-κB, PI3-K/Akt, and MAPKs were investigated in 
macrophage proinflammatory responses after stimulation 
with HBHA. Results: HBHA robustly activated the ex-
pression of mRNA and protein of both TNF-α and IL-6, and 
induced phosphorylation of NF-κB, Akt, and MAPKs in 
BMDMs. Both TNF-α and IL-6 production by HBHA was 
regulated by the NF-κB, PI3-K, and MAPK pathways. 
Furthermore, PI3-K activity was required for the HBHA-in-
duced activation of ERK1/2 and p38 MAPK, but not JNK, 
pathways. Conclusion: These data suggest that mycobacte-
rial HBHA significantly induces proinflammatory responses 
through crosstalk between the PI3-K and MAPK pathways in 
macrophages.
[Immune Network 2011;11(2):123-133]
INTRODUCTION
Mycobacterium tuberculosis  (Mtb) or mycobacterial Ags ini-
tiate proinflammatory responses in mononuclear phagocytes 
by  interaction  with  a  variety  of  signaling  molecules/machi-
neries. The relationships between specific mycobacterial com-
ponents and signaling pathways are crucial for the induction 
of appropriate host responses, such as mounting a protective 
immune response, during mycobacterial infection (1). One of 
the Mtb-Ags, heparin-binding hemagglutinin (HBHA), is im-
portant for adherence to epithelial cells (2). This protein can 
induce  mycobacterial  aggregation,  hemagglutination,  and 
binding to heparin sulfate proteoglycans through post-transla-
tional  modifications  in  the  C-terminal  lysine-rich  domain  of 
the protein (3,4). In addition, HBHA protein reacts with sera 
from  tuberculosis  (TB)  patients,  but  not  from  healthy  in-
dividuals,  suggesting  potent  immunogenicity  during  myco-
b a c t e r i a l  i n f e c t i o n s  ( 4 ) .  M o r e o v e r ,  H B H A  h a s  b e e n  w i d e l y  
studied  for  its  potential  to  elicit  effective  host  immune  re-
sponses against TB (5). However, little is known regarding 
the molecular mechanisms by which HBHA modulates host 
innate  immune  responses.
    Upon  mycobacterial  infection,  the  engagement  of  myco-
bacteria with innate receptors in host cells leads to the activa-
tion of signaling pathways that then results in the induction 
o f  i n f l a m m a t o r y  c y t o k i n e s  a n d  a n t i m i c r o b i a l  e f f e c t o r s  ( 6 ) .  
Importantly, the mycobacterial cell wall contains a number of HBHA-induced Inflammatory Signaling
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proinflammatory TLR2 ligands, including lipoproteins and lip-
oarabinomannan, and induces activation of the MAPKs and 
NF-κB  pathways  (1,7).  Subsequent  innate  responses  likely 
serve to decrease the inoculum size during the initial infection 
and drive an adaptive immune response (6). The MAPK path-
ways play an important role in enhancing antimycobacterial 
activity and production of immune effector molecules, includ-
ing TNF-α (1). The proinflammatory cytokine TNF-α plays 
a crucial role in defense against mycobacterial infection in-
cluding  phagocytosis,  intracellular  killing,  stimulating  T  cell 
activation, and granuloma formation (8,9). Our previous stud-
ies have reported that the proinflammatory cytokines TNF-α, 
IL-1β, and IL-6 are up-regulated in monocytes and macro-
phages isolated from the early stages of active pulmonary TB 
patients (10,11). In addition, it was shown that activation of 
ERK1/2 and p38 MAPK, proinflammatory cytokine secretion, 
and  apoptotic  activities  were  greater  in  monocytes  or  neu-
trophils from TB patients compared with healthy control sub-
jects  (11-13).
    Although  previous  studies  of  TB  and  mycobacterial  Ags 
have contributed to marked  advances  in our knowledge of 
the host protective immune responses, a number of critical 
questions are not well understood. Here, we present the in-
tracellular signaling pathways activated by HBHA stimulation 
in  murine  bone  marrow-derived  macrophages  (BMDMs). 
First, we determined whether HBHA Ag induced TNF-α and 
IL-6 production in BMDMs. We then examined the roles of 
PI3-K and MAPKs: p38, JNK, and ERK1/2 in BMDMs. We also 
found  that  the PI3-K and  MAPK pathways  contribute to an 
induction  of  HBHA-induced  TNF-α and  IL-6  production  in 
BMDMs. To the best of our knowledge, this is first study to 
investigate  the  molecular  mechanisms  underlying  the  regu-
lation  of  innate  immune  responses  induced  by  HBHA.
MATERIALS AND METHODS
Mice and cell culture
Wild-type  C57BL/6  mice  were  purchased  from  KOATECH 
(Pyungtek, Korea). All animal procedures were conducted in 
accordance  with  the  guidelines  of  the  Institutional  Animal 
Care  and  Use  Committee,  Chungnam  National  University. 
BMDMs were differentiated for 5∼7 d in media containing 
M-CSF (R&D systems, Minneapolis, MN, USA), as described 
previously (1). The culture media contain DMEM (Gibco-BRL, 
Gaithersburg,  NY,  USA)  with  10%  heat-inactivated  FBS 
(Gibco-BRL), 1 mM sodium pyruvate, 50 U/ml penicillin, 50
μg/ml  streptomycin  and  5×10
5  M  ß-mercaptoethanol,  so-
dium pyruvate, non-essential amino acids, penicillin G (100 
IU/ml),  and  streptomycin  (100μg / m l ) .  T h e  m o u s e  m a c r o -
phage cell line RAW264.7 (American Type Culture Collection; 
ATCC TIB-71) was maintained in complete medium (DMEM 
with  10%  FBS)  with  sodium  pyruvate,  non-essential  amino 
a c i d s ,  p e n i c i l l i n  G  ( 1 0 0  I U / m l ) ,  a n d  s t r e p t o m y c i n  ( 1 0 0μg/ 
ml).
Reagents, DNA, and Abs
A l l  r e a g e n t s  a n d  c h e m i c a l s  w e r e  p u r c h a s e d  f r o m  S i g m a -  
Aldrich except those noted below, which were obtained from 
the  indicated  suppliers:  BAY  11-7082,  LY294002,  Wortman-
nin,  U0126,  SB203580,  and  SP600125  were  purchased  from 
Calbiochem (San Diego, CA, USA). Specific Abs against total 
Akt, phospho-Akt (Ser473), phospho-IκB-α (Ser32/36), pho-
spho-ERK1/2 (Thr202/Tyr204), phospho-p38 (Thr180/Tyr182), 
and phospho-JNK (Thr183/Tyr185) were purchased from Cell 
signaling  Technology  (Cell  signaling,  Beverly,  MA,  USA). 
Anti-β-actin  (I-19),  anti-IκB-α  ( C - 2 1 ) ,  a n d  a n t i - p h o s -
pho-NF-κB  p65  (C-20)  were  purchased  from  Santa  Cruz 
Biotechnology  (Santa  Cruz,  CA,  USA).  DMSO  (Sigma,  St. 
Louis, MO, USA) was added to cultures at 0.1% (v/v) as a 
solvent control. The dominant negative (DN)-p38, DN-MEK1 
and DN PI3-K p110α constructs were a kind gift from Dr. 
Eui-Ju  Choi  (Korea  University,  Seoul,  Korea).  Cells  were 
transfected  using  LipofectAMINE  as  indicated  by  the  manu-
facturer  (Invitrogen,  Carlsbad,  CA,  USA).
Purification of recombinant HBHA
Methylated, recombinant HBHA was expressed in M. smeg-
matis (rMS-HBHA), as previously described with slight mod-
ifications (14,15). Purified recombinant HBHA was dialyzed 
against PBS (pH 7.2), applied to a column with immobilized 
polymyxin  B  (Detoxi-Gel  Endotoxin  Removing  Gel;  Pierce, 
Rockford,  IL,  USA)  to  reduce  the  level  of  endotoxin,  fil-
ter-sterilized,  and  then  frozen  at  −20
oC .  P r o t e i n  c o n c e n -
trations were estimated using the bicinchoninic acid protein 
assay kit (Pierce), with BSA as the standard. The endotoxin 
content in HBHA was 0.017 ng/μg protein, as determined 
by the limulus-amebocyte-lysate test (QCL1000; BioWhittaker, 
Walkersville,  MD,  USA).
ELISA assay and Western blot
BMDMs were treated for the times indicated and processed 
for analysis by a sandwich ELISA and Western blot, as pre-HBHA-induced Inflammatory Signaling
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viously described (1). For the sandwich ELISA, cytokine lev-
els in cell culture supernatants were determined using Duoset 
Ab pairs (BD PharMingen, San Diego, CA, USA) for the de-
tection of TNF-α and IL-6, as described (1). All assays were 
performed  as  recommended  by  the  manufacturers.  For 
Western blot analysis, primary Abs were used at a 1：1,000 
dilution. The blots were then detected by the ECL detection 
system according to the recommended procedure (Amersham- 
Pharmacia,  Freiburg,  Germany).
RNA isolation and RT-PCR assay
F o r  s e m i - q u a n t i t a t i v e  R T - P C R  a n a l y s i s ,  t o t a l  R N A  w a s  e x -
tracted  from  BMDMs  (1×10
6)  using  TRIzol  (Invitrogen),  as 
previously described (11). For PCR amplifications of specific 
cDNAs derived from TNF-α, IL-6, and β-actin mRNAs, three 
sets  of  sense  and  antisense  oligonucleotides  were  used. 
Primer  sequences  were  as  follows:  mTNF-α (forward:  5’- 
CGGACTCCGCAAAGTCTAAG-3’, reverse: 5’-ACGGCATGGA-
TCTCAAAGAC-3’), mIL-6 (forward: 5’-GGAAATTGGGGTAG-
GAAGGA-3’,  reverse:  5’-CCGGAGAGGAGACTTCACAG-3’), 
and  β-actin (forward:  5’-TCATGAAGTGTGACGTTGACATC-
CGT-3’, reverse: 5’-CCTAGAAGCATTTGCGGTGCACGATG-3’). 
PCR amplification  was performed with  an initial  denaturing 
step at 95
oC for 5 min, followed by 30 cycles of denaturation 
(95
oC, 1 min), annealing (58
oC, 1 min), and extension (72
oC, 
1 min), then a further extension at 72
oC for 10 min. The PCR 
products  were  electrophoresed  in  1.5%  agarose  gels  in  the 
presence of ethidium bromide, visualized by ultraviolet fluo-
rescence, and recorded by a digital camera connected to a 
computer  (SYNGENE,  Gene  Genius  Imaging  System).
Immunofluorescence microscopy for NF-κB translo-
cation
For NF-κB translocation analysis, BMDMs were treated with 
HBHA for 1 h and then fixed with 4% (w/v) paraformalde-
hyde in PBS for 10 min at room temperature (RT). Cells were 
then permeabilized with 0.25% (v/v) Triton X-100 in PBS for 
15 min at RT and blocked for 1 h in PBS containing 3% BSA. 
The cells were immunostained with rabbit anti-mouse NF-κB 
p65 (1：200 dilution) for 2 h at RT. After washing with PBS, 
cells were incubated with 1：200 dilutions of anti-rabbit im-
munoglobulin-conjugated AlexaFluor 488 (Molecular Probes, 
Eugene, OR, USA) for 1 h at RT. Nucleus were visualized by 
incubation  with  DAPI  (1μg/ml,  Sigma).  The  nuclear  trans-
location of NF-κB p65 was visualized using a Olympus BX51 
fluorescence microscope (DP ver. 1.2.1.108, Olympus, Japan).
Statistical analysis
For  statistical  analysis,  data  obtained  from  independent  ex-
periments are presented as the mean±SD and were analyzed 
using  the  Student’s  t-test  with  Bonferroni  adjustment  or  an 
ANOVA for multiple comparisons. Differences were consid-
e r e d  s t a t i s t i c a l l y  s i g n i f i c a n t  f o r  p ＜0.05.
RESULTS
HBHA induces the expression of TNF-α and IL-6 mRNA 
and protein in BMDMs
Several mycobacterial Ags, including methylated HBHA, play 
an essential role in the induction of immunogenicity during 
tuberculous  pleurisy  infection  (10-12).  We  first  examined 
whether purified mycobacterial HBHA induced the expression 
of  TNF-α  and  IL-6  mRNA  in  BMDMs.  Semiquantitative 
RT-PCR analysis showed that HBHA significantly induced the 
expression of TNF-α and IL-6 mRNA after 3 h of stimulation 
in BMDMs. Peak expression of TNF-α and IL-6 mRNA oc-
curred 6 h after stimulation with HBHA (Fig. 1A). In addition, 
secretion of TNF-α and IL-6 protein was assayed in BMDMs 
after  HBHA  stimulation.  Treatment  of  BMDMs  with  HBHA 
significantly induced production of TNF-α and IL-6 after 6 
h with a peak at 18 h (Fig. 1B). These data demonstrate that 
HBHA strongly induces proinflammatory cytokine expression 
by  BMDMs.
HBHA robustly activates the NF-κB and MAPK signal-
ing pathway in macrophages
NF-κB is a central regulator of inflammatory responses, and 
activation  of  NF-κB  is  required  for  the  transcriptional  in-
duction of many proinflammatory mediators involved in in-
nate  immunity,  including  cellular  adhesion  molecules,  cyto-
kines, and growth factors (16). After stimulation with HBHA 
for the times indicated, expression of IκB-α was dramati-
cally attenuated after 15∼30 min, whereas IKKα/β phos-
phorylation was strongly induced after 15∼30 min (Figs. 2A 
and B). The MAPK pathways are crucial for macrophage sig-
naling during mycobacterial infection (17,18). We next exam-
ined  whether  HBHA  induced  MAPK  activation  in  BMDMs. 
HBHA stimulation induced MAPK (ERK 1/2, p38, and JNK) 
activation within 15 min of stimulation, with a peak at 15∼30 
min (Figs. 2A and C). These data indicate that HBHA robustly 
activates  NF-κB  and  MAPK  signaling  pathways  in  macro-
phages.HBHA-induced Inflammatory Signaling
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Figure 1. Kinetics of proinflammatory responses induced by HBHA 
in macrophages. BMDMs were stimulated with HBHA (1μg/ml) for 
the indicated periods of time. (A) Cells were harvested and 
semi-quantitative RT-PCR analysis of TNF-α and IL-6 mRNA level was
performed. The relative densities of the expression levels were 
analyzed by densitometry. All densitometry values were normalized 
to that of β-actin mRNA. Top: representative gel images showing the 
products of RT-PCR analysis, Bottom: densitometric analysis. (B) The 
supernatants were harvested after the times indicated for assessment 
of TNF-α and IL-6 levels by ELISA. Mean results and densitometry
values are depicted as mean±SD of three independent determina-
tions. Significant differences (*p＜0.05, **p＜0.01, ***p＜0.001) as 
compared with control cultures.
NF-κB activation is required for HBHA-induced TNF-α 
and IL-6 production
W e  ne x t  in ve st ig a te d  t h e r ol e o f N F -κB  in  HBHA-induced 
proinflammatory  cytokine  production  by  BMDMs.  We  first 
confirmed translocation of NF-κB p65 into the nucleus after 
stimulation  with  HBHA  (Fig.  3A).  Pretreatment  of  BMDMs 
with an NF-κB inhibitor (BAY 11-7082, an inhibitor of IκB 
phosphorylation) significantly attenuated production of TNF-
α and IL-6 in a dose-dependent manner (Fig. 3B). Further-
more, pre-treatment of BMDMs with other NF-κB inhibitors 
(IKK-2 inhibitor and NF-κB activation inhibitor) significantly 
reduced TNF-α and IL-6 mRNA expression (data not shown). 
These results indicate a critical role for NF-κB in the modu-
lation  of  HBHA-induced  inflammatory  responses.
HBHA-induced TNF-α and IL-6 expression is depen-
dent on the PI3-K/Akt pathways
In previous studies, we found a rapid phosphorylation of the 
PI3-K/Akt  pathway  in  human  monocytes  after  stimulation 
with the 30 kDa or purified protein derivative (PPD) of Mtb 
(19,20).  However,  the  nature  of  PI3-K/Atk  activation  after 
HBHA  stimulation  remains  unknown.  We  also  investigated 
whether HBHA stimulation induces activation of the Akt path-
way in BMDMs. As shown in Fig. 4A, HBHA induced phos-
phorylation of Akt within 5 min of stimulation and marked 
activation  of  Akt  occurred  within  2∼8  h  of  HBHA 
stimulation.
    To examine the role of the PI3-K/Akt pathway in HBHA-in-
duced TNF-α and IL-6 production, BMDMs were pre-treated 
with LY294002 or Wortmannin, which are pharmacologic in-
hibitors of PI3-K, prior to HBHA stimulation. TNF-α and IL-6 
m RN A  a nd  pr ot e in  l ev e ls i n t he  c el ls an d  su pe rn at an ts ,  r e-
spectively, were then examined. As shown in Figs. 4B and 
C, pre-treatment with LY294002 or Wortmannin significantly 
inhibited  TNF-α and  IL-6  mRNA  expression  (Fig.  4B)  and 
protein production (Fig. 4C) in HBHA-treated BMDMs. Fur-
thermore, these data were confirmed using PI3-K p110α-DN. 
RAW264.7 cells were transfected with the PI3-K p110α-DN 
construct or mock control before stimulation by HBHA and 
then  subjected  to  ELISA.  A  similar  significant  inhibition  of 
TNF-α and IL-6 production was observed in RAW264.7 cells 
transfected with the PI3K p110α-DN mutant construct com-
pared  with  the  mock  control  vector  (Fig.  4D).  These  data 
suggest that the PI3-K/Akt pathway is essential for regulation 
of  HBHA-induced  TNF-α and  IL-6  production  by  macro-
phages.
HBHA-induced TNF-α and IL-6 expression is depen-
dent on the MAPK pathway
We  next  investigated  the  possible  involvement  of  the  ERK 
1/2,  p38  MAPK,  or  JNK  pathways  in  HBHA-induced  proin-
flammatory responses. Cells were stimulated with HBHA and 
cultured for 6 or 18 h to assess mRNA expression and TNF-α 
and IL-6 production. As shown in Figs. 5A and B, HBHA-in-
duced  TNF-α and  IL-6  expression  and  protein  production 
were significantly inhibited in BMDMs pretreated with specific 
MAPK  inhibitors  [inhibitors  of  MEK  (U0126,  PD98059),  p38 
MAPK  (SB203580),  and  JNK  (SP600125)].HBHA-induced Inflammatory Signaling
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Figure 2. Kinetics of NF-κB and 
MAPK signaling pathway activation 
in macrophages after stimulation 
with HBHA. (A) BMDMs were sti-
mulated with HBHA (1μg/ml) for 
the indicated periods of time. Cell 
lysates were harvested and sub-
jected to Western blot analysis for 
phosphorylated IKK-α/β. The same
blots were washed and blotted for I
κB-α and phosphorylated MAPKs 
(p-ERK, p-p38, p-JNK). β-actin was 
probed as a loading control. Data 
are representative of three indepen-
dent determinations with similar 
results. (B) Densitometric analysis of
Western blot bands for phospho- 
IKK-α/β and IκB-α; both were 
normalized with β-actin. (C) Densi-
tometric analysis of Western blot 
bands for phospho-ERK, p38, and 
JNK were normalized to β-actin.
    Additionally,  RAW264.7  cells  were  transfected  with  p38 
MAPK-DN and MEK1-DN mutant constructs or a mock control 
vector prior to stimulation by HBHA. We observed a signi-
ficant inhibition of TNF-α and IL-6 production in RAW264.7 
cells transfected with the p38 MAPK-DN or MEK1-DN mutant 
construct compared with the mock control vector (Fig. 5C). 
These  results  indicate  that  HBHA-induced  TNF-α and  IL-6 
production is regulated by the MAPKs (ERK 1/2, p38 MAPK, 
and  JNK)  pathway  in  macrophages.
PI3-K inhibition attenuates HBHA-induced ERK1/2 and 
p38, but not JNK, activity in BMDMs
Mycobacteria and mycobacterial components are potent acti-
vators of the PI3-K/Akt and MAPK pathways in macrophages 
(17,18,21-23).  Previously,  it  was  shown  that  the  PI3-K  and 
Akt pathways modulate the activation of ERK1/2 in response 
to Mtb or mycobacterial Triton X-100-solubilized protein Ag 
(24). We further determined whether HBHA-dependent PI3-K 
activation regulates the downstream MAPK pathways. To in-
vestigate the role of PI3-K in HBHA-induced MAPK activation, 
BMDMs  were  pretreated  with  Wortmannin  or  LY294002, 
s t i m u l a t e d  w i t h  H B H A ,  a n d  t h e n  a s s e s s e d  b y  W e s t e r n  b l o t  
analysis  for  ERK1/2,  p38  MAPK,  and  JNK  phosphorylation. 
As shown in Fig. 6, inhibition of PI3-K significantly attenuated 
HBHA-induced  phosphorylation  of  Akt,  as  well  as  that  of 
ERK1/2 and p38, in BMDMs. However, the activation of JNK HBHA-induced Inflammatory Signaling
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Figure 3. NF-κB activation is required for HBHA-induced TNF-α and
IL-6 production by macrophages. (A) NF-κB translocation by HBHA.
BMDMs were stimulated with HBHA (1μg/ml) for 1 h and immuno-
stained with anti-NF-κB-p65 and anti-rabbit-Alexa Fluor 488. Left, 
representative images of three independent determinations with 
similar results. Scale bar=20μm. Right: quantification of data, NF-κ
B-nuclear translocated cells were counted manually in DAPI-stained
BMDMs. Data shown represent the means±SD of three independent
samples, with each experiment including at least 200 cells scored in
five random fields. (B) BMDMs were preincubated for 45 min with 
BAY 11-7082 (BAY; 0.3, 1, 3μM), prior to stimulation with HBHA 
(1μg/ml). Supernatants were harvested at 18 h and protein levels 
were determined by ELISA. Data represent the mean±SD of three 
independent determinations. Significant differences (*p＜0.05, **p
＜0.01) as compared with HBHA-treated cells. U: unstimulated, SC: 
solvent control (0.1% DMSO).
was not modulated by inhibition of the PI3-K pathway. These 
results  show  that  PI3-K/Akt  activity  is  required  for  the 
HBHA-induced activation of ERK 1/2 and p38 MAPK, but not 
JNK.
DISCUSSION
In the present study, we demonstrate the molecular mecha-
nisms underlying the regulation of the proinflammatory cyto-
kines TNF-α and IL-6 by the PI3-K/Akt, p38, and ERK 1/2 
MAPK pathways in response to the mycobacterial HBHA in 
murine macrophages. Mycobacteria and their components are 
potent activators of macrophages, which are able to produce 
proinflammatory  mediators  that  are  essential  for  innate  de-
fense and induction of the acquired immune response against 
mycobacteria (17,21,25,26). The mycobacterial HBHA, espe-
cially the methylated form, is known to be essential for effec-
tive protective immunity, which is comparable to that induced 
by  vaccination  with  Bacillus  Calmette-Guérin  (27).  Further-
more,  previous  studies  reported  that  HBHA  is  significantly 
more sensitive than early secreted antigenic target-6 and more 
specific than PPD for the detection of latent TB infection (28). 
These observations strongly suggest that mycobacterial HBHA 
is  involved  in  the  pathogenesis  of  TB  and  might  be  useful 
in  diagnosis.  However,  the  role  of  HBHA  in  the  induction 
of  innate  and  inflammatory  responses  during  mycobacterial 
i n f e c t i o n  h a s  n o t  b e e n  c h a r a c t e r i z e d .
    We  found  that  levels  of  the  proinflammatory  cytokines 
TNF-α and IL-6 were increased in BMDMs stimulated with 
HBHA.  Vaccination  with  HBHA  induces  IFN-γ production 
by both CD4
＋ and CD8
＋ T cells, and CD8
＋ cytotoxic T cell 
responses (29). To the best of our knowledge, this is the first 
report that HBHA actively induces proinflammatory immune 
responses in macrophages. TNF-α, a critical proinflammatory 
cytokine,  plays  an  essential  role  in  the  host  protective  im-
mune responses against mycobacterial infection (30). We pre-
viously reported that mycobacterial Ags up-regulated the pro-
duction of TNF-α, IL-1, and IL-6 in monocytes/macrophages 
isolated from early active TB patients, when compared with 
those from healthy controls (10,11). In addition, activation of 
ERK1/2 and p38 MAPK, proinflammatory cytokine secretion, 
and  apoptotic  activities  were  greater  in  monocytes  or  neu-
trophils from TB patients, compared with healthy control sub-
jects (11-13). Combined with our findings, these reports sug-
gest that HBHA contributes to the immunopathology of TB 
through active induction of proinflammatory cytokine release.
  N F - κB is a central mediator of the inducible transcription 
of  various  proinflammatory  genes  in  innate  immune  re-
sponses (31). Previous studies have shown that mycobacterial 
infection, or mycobacterial products, act through TLRs to trig-
ger the MAPK pathways, leading to activation of transcription 
factors,  including  NF-κB  (17,24,32).  We  found  HBHA-in-
duced  increases  in  IKKα/β phosphorylation,  as  well  as 
translocation of p65 from the cytosol to the nucleus. Impor-
tantly,  inhibition  of  NF-κB  significantly  reduced  HBHA-in-
duced  proinflammatory  cytokine  secretion.  These  data  are 
consistent  with  the  observed  strong  induction  of  proin-
f lam m at or y cy t ok in e ex p re ssi on  b y  h ea t sh oc k  pro t ei n (3 3) 
and a 19-kDa lipoprotein (34) from Mtb. Taken together, our 
data suggest that NF-κB activation plays an essential role in 
HBHA stimulation of proinflammatory cytokine secretion by HBHA-induced Inflammatory Signaling
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Figure 4. Effects of the PI3-K/Akt signaling pathways on HBHA-induced TNF-α and IL-6 expression by macrophages. (A) BMDMs were stimulated
with HBHA (1μg/ml) for the times indicated. The cell lysates were then harvested and subjected to Western blot analysis for phosphorylated 
Akt. The same blots were washed and blotted for total Akt as the loading control. Top: representative gel image was shown, Bottom: densitometric
analyses of Western blot bands for phospho-Akt was normalized to total Akt. Data are representative of three independent determinations with 
similar results. (B, C) Cells were pretreated with LY294002 (LY; 5, 10, 20μM) or Wortmannin (WM; 100, 200, 300 nM) for 45 min prior to
stimulation with HBHA (1μg/ml) for 6 h (for B) or 18 h (for C). (B) Total RNA was purified and semi-quantitative RT-PCR was used to determine
TNF-α and IL-6 expression in BMDMs. Top: representative gel image of three independent replicates was shown, Bottom: the relative densities
of expression levels were analyzed by densitometry. All densitometry values were normalized to those of β-actin mRNA. (C) Supernatants were
harvested at 18 h, and TNF-α and IL-6 levels were measured by ELISA. Data shown are the mean±SD of three determinations. (D) RAW264.7
cells were transfected with PI3-K p110α-DN or empty vector for 24 h prior to stimulation with HBHA (1μg/ml) for 18 h. The supernatants 
were then harvested and subjected to ELISA. Significant differences (*p＜0.05, **p＜0.01, ***p＜0.001), compared with HBHA-treated cells
or Mock control. U: unstimulated, SC: solvent control (0.1% DMSO).
BMDMs.
    Mycobacteria  induce  the  PI3-K  (35,36)  and  MAPK  intra-
cellular signaling cascades (1,21). In mycobacterial infections, 
the PI3-K pathway plays a role in human monocyte antimyco-
bacterial activity (11,37). The MAPK signaling pathways are 
activated  upon  mycobacterial  infection,  and  have  been  im-HBHA-induced Inflammatory Signaling
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Figure 5. MAPK signaling pathways are required for HBHA-induced TNF-α and IL-6 expression by macrophages. (A) BMDMs were pretreated
with p38 inhibitor (SB203580; 1, 5, 10μM), MEK-1 inhibitor (U0126; 5, 10, 20μM), or JNK inhibitor (SP600125; 5, 20, 30μM) prior to 
stimulation with HBHA (1μg/ml). Cells were then harvested at 6 h, and total RNA purified and subjected to semi-quantitative RT-PCR analysis
for assessment of TNF-α and IL-6 expression. Top: representative gel image of three independent replicates was shown, Bottom: the relative 
densities of expression levels were analyzed by densitometry. All densitometry values were normalized to those of β-actin mRNA. (B) BMDMs
were pretreated with p38 inhibitor (SB203580, 10μM), MEK-1 inhibitor (PD98059 and U0126, 20μM), or JNK inhibitor (SP600125, 20μM)
prior to stimulation with HBHA (1μg/ml). The supernatants from BMDMs were collected 18 h after stimulation of HBHA, and subjected to 
ELISA analysis for assessment of TNF-α and IL-6 production. Data shown are the mean±SD of three determinations. (C) RAW264.7 cells were 
transfected with p38 MAPK-DN, MEK-1-DN, or empty vector prior to stimulation with HBHA (1μg/ml) for 18 h. The supernatants from cells 
were harvested and subjected to ELISA for determination of TNF-α and IL-6 production. Significant differences (*p＜0.05, **p＜0.01, ***p
＜0.001) as compared with control cultures. U: unstimulated, SC: solvent control (0.1% DMSO), SB: SB203580, PD: PD98059, SP: SP600125.
plicated in pathogenesis (18). The mycobacterial Ags 38 kDa 
and MTB12 can induce activation of ERK1/2 and p38 MAPK, 
and subsequent cytokine secretion in monocytes from active 
p u l m o n a r y  T B  p a t i e n t s  ( 1 1 , 3 8 ) .  A l t h o u g h  H B H A  i s  w i d e l y  
studied for its potential to trigger effective host immune re-
sponses against TB (5), little is known regarding the signaling 
mechanisms  underlying  proinflammatory  cytokine  secretion 
by macrophages. Here, we suggest that mycobacterial HBHA 
can  induce  intracellular  signaling  pathways,  such  as  PI3-K 
and MAPK, that are required for production of TNF-α and 
IL-6  in  BMDMs.
    Previously,  we  reported  that  macrophage  recognition  of 
mycobacteria  and their  Ags via  innate receptors  resulted  in 
the activation of the MAPK and PI3-K/Akt pathways in mono-
cytes/macrophages  (11,21,39).  The  PI3-K  and  MAPK  path-
ways contribute to proinflammatory cytokine secretion in re-
sponse to the PPD and 30 kDa Ag of Mtb in human mono-
cytes (19,20). Additionally, the PI3-K/Akt and ERK1/2 path-
ways are important for TNF-α expression in human mono-
cyte-derived  macrophages  after  treatment  with  Mtb  H37Rv 
and Triton X-100-solubilized protein purified from Mtb (24). 
Interestingly, HBHA elicited a biphasic response, with an ear-
ly peak of phospho-Akt observed after 5 min of stimulation, 
followed by a drop at 30∼60 min and then a steady increase 
up to 8 h. These data are partly consistent with previous stud-
ies in which PI3-K/Akt showed a similar biphasic activation, 
i.e., by Francisella infection in murine macrophages (40) and 
LPS  or  α-lipoic  acid  in  human  monocytic  THP-1  cells 
(41,42). Currently, the mechanisms by which phosphorylation 
of  Akt  at  Ser473  are  modulated  during  the  early  and  late 
phases after stimulation of HBHA are not known. Future stud-
ies will likely elucidate the molecular mechanisms by which HBHA-induced Inflammatory Signaling
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Figure 6. PI3-K/Akt pathway is the upstream signaling activator for p38
and ERK1/2 signaling pathways in macrophages after stimulation with
HBHA. (A) BMDMs were incubated with LY294002 (LY; 5, 10, 20 
μM) or Wortmannin (WM; 100, 200, 300 nM) for 45 min prior to
treatment with HBHA (1μg/ml). Cell lysates were then harvested (for
p-Akt, at 5 min; for MAPKs, at 30 min), and subjected to Western
blot analysis for p-Akt and MAPKs (p38, ERK, JNK). The same blots
were stripped, washed, and re-probed with β-actin as a loading 
control. Data are representative of three independent determinations
with similar results. (B) Densitometric analysis of the Western blot 
bands for p-Akt, p-ERK, p-p38, and p-JNK were normalized to total-Akt
(for p-Akt) or β-actin (for MAPKs). Significant differences (*p＜0.05, 
**p＜0.01, ***p＜0.001), compared with control cultures. U: 
unstimulated, SC: solvent control (0.1% DMSO).
Akt phosphorylation is modulated and the exact roles of Akt 
phosphorylation during the early and late phases after HBHA 
stimulation.
  Our results also demonstrate that PI3-K is a necessary up-
stream activator of the p38 and ERK1/2 MAPK pathways in 
BMDMs  after  stimulation  with  HBHA.  Crosstalk  between 
PI3-K/Akt and MEK-ERK pathways in different cell types has 
been demonstrated (43). Previously, it was reported that the 
PI3-K pathway is an upstream signal for ERK1/2 MAPK activa-
tion  (24).  However,  this  study  did  not  determine  how  im-
portant HBHA is in proinflammatory innate responses or in 
the pathogenesis of TB. However, our data suggest a poten-
tial role for HBHA in the proinflammatory response to myco-
bacterial infection, since HBHA is a strong stimulator of proin-
flammatory  cytokine  secretion  and  an  NF-κB  activator. 
Recently,  Jung  et  al.  demonstrated  that  HBHA  up-regulates 
the  proinflammatory  cytokines  IL-6,  IL-12,  IL-1β,  TNF-α, 
and  CCR7  in  dendritic  cells ( 4 4 ) .  I n  t h e  s a m e  s t u d y ,  
HBHA-treated dendritic cells activated naïve T cells and po-
larized  them  to  secrete  IFN-γ (44).  Other  studies  have 
shown that HBHA-induced IFN-γ production in alveolar and 
pleural lymphocytes is higher in pulmonary or pleural TB pa-
tients  than  in  non-TB  controls  (45).  Moreover,  HBHA  is 
strongly  recognized  by  sera  from  pulmonary  TB  patients 
when compared with healthy controls (46). Taken together, 
our data strongly suggest that HBHA plays a potentially pleio-
tropic  function  in  protective  immunity  (through  IFN-γ-de-
pendent  protective  immunity)  and  inflammatory  responses 
(through  inflammatory  cytokine  production)  in  TB.
    Collectively, the data presented in this study provide a nov-
el insight into molecular signaling by HBHA through activa-
tion  of  the  NF-κB  and  PI3-K/Akt-p38-ERK1/2  MAPK  path-
ways,  which  are  responsible  for  the  induction  of  pro-in-
flammatory  responses  during  TB  infection.  In  addition,  our 
data reveal the key immunological processes induced by im-
portant  human  pathogens,  including  mycobacteria,  and  this 
information may assist in the rational design of more effective 
vaccines  and  adjuvants.
ACKNOWLEDGEMENTS
This  study  was  financially  supported  by  research  fund  of 
Chungnam National University in 2009. We thank Dr. Gang- 
Min  Hur  (Chungnam  National  University,  Daejeon,  Korea) 
and  Eui-Ju  Choi  (Korea  University,  Seoul,  Korea)  for  kind 
provision of constructs. The authors have no financial conflict 
of  interest.
CONFLICTS OF INTEREST
The  authors  have  no  financial  conflict  of  interest.
REFERENCES
1. Jo EK, Yang CS, Choi CH, Harding CV: Intracellular signal-
ling  cascades  regulating  innate  immune  responses  to 
Mycobacteria: branching out from Toll-like receptors. Cell 
Microbiol  9;1087-1098,  2007
2. Menozzi  FD,  Bischoff  R,  Fort  E,  Brennan  MJ,  Locht  C: 
Molecular  characterization  of  the  mycobacterial  hep-
arin-binding hemagglutinin, a mycobacterial adhesin. Proc HBHA-induced Inflammatory Signaling
Ki-Hye Kim, et al.
132 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 2 April 2011
Natl  Acad  Sci  U  S  A  95;12625-12630,  1998
3. Pethe K, Bifani P, Drobecq H, Sergheraert C, Debrie AS, 
Locht  C,  Menozzi  FD:  Mycobacterial  heparin-binding  he-
magglutinin  and  laminin-binding  protein  share  antigenic 
methyllysines  that  confer  resistance  to  proteolysis.  Proc 
Natl  Acad  Sci  U  S  A  99;10759-10764,  2002
4. Menozzi FD, Rouse JH, Alavi M, Laude-Sharp M, Muller J, 
Bischoff R, Brennan MJ, Locht C: Identification of a hep-
arin-binding hemagglutinin present in mycobacteria. J Exp 
Med  184;993-1001,  1996
5. Parra M, Pickett T, Delogu G, Dheenadhayalan V, Debrie 
AS, Locht C, Brennan MJ: The mycobacterial heparin-bind-
ing hemagglutinin is a protective antigen in the mouse aer-
osol  challenge  model  of  tuberculosis.  Infect  Immun  72; 
6799-6805,  2004
6. Korbel DS, Schneider BE, Schaible UE: Innate immunity in 
tuberculosis: myths and truth. Microbes Infect 10;995-1004, 
2008
7. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, 
Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, 
Brennan PJ, Bloom BR, Godowski PJ, Modlin RL: Host de-
fense  mechanisms  triggered  by  microbial  lipoproteins 
through  toll-like  receptors.  Science  285;732-736,  1999
8. Toossi  Z:  Cytokine  circuits  in  tuberculosis.  Infect  Agents 
Dis  5;98-107,  1996
9. Bermudez LE, Young LS: Tumor necrosis factor, alone or 
in combination with IL-2, but not IFN-gamma, is associated 
with macrophage killing of Mycobacterium avium complex. 
J  Immunol  140;3006-3013,  1988
10. Lee JS, Song CH, Lim JH, Kim HJ, Park JK, Paik TH, Kim 
CH, Kong SJ, Shon MH, Jung SS, Jo EK: The production 
of tumour necrosis factor-alpha is decreased in peripheral 
blood  mononuclear  cells  from  multidrug-resistant  tuber-
culosis patients following stimulation with the 30-kDa anti-
gen of Mycobacterium tuberculosis. Clin Exp Immunol 132; 
443-449,  2003
11. Jung  SB,  Yang  CS,  Lee  JS,  Shin  AR,  Jung  SS,  Son  JW, 
Harding CV, Kim HJ, Park JK, Paik TH, Song CH, Jo EK: 
The  mycobacterial  38-kilodalton  glycolipoprotein  antigen 
activates the mitogen-activated protein kinase pathway and 
release of proinflammatory cytokines through Toll-like re-
ceptors 2 and 4 in  human  monocytes. Infect Immun 74; 
2686-2696,  2006
12. Yang  CS,  Shin  DM,  Lee  HM,  Son  JW,  Lee  SJ,  Akira  S, 
Gougerot-Pocidalo MA, El-Benna J, Ichijo H, Jo EK: ASK1- 
p38 MAPK-p47phox activation is essential for inflammatory 
responses during tuberculosis via TLR2-ROS signalling. Cell 
Microbiol  10;741-754,  2008
13. Alemán M, Schierloh P, de la Barrera SS, Musella RM, Saab 
MA, Baldini M, Abbate E, Sasiain MC: Mycobacterium tu-
berculosis triggers apoptosis in peripheral neutrophils in-
volving toll-like receptor 2 and p38 mitogen protein kinase 
in tuberculosis patients. Infect Immun 72;5150-5158, 2004
14. Delogu G, Bua A, Pusceddu C, Parra M, Fadda G, Brennan 
MJ, Zanetti S: Expression and purification of recombinant 
methylated  HBHA  in  Mycobacterium  smegmatis.  FEMS 
Microbiol  Lett  239;33-39,  2004
15. Shin AR, Lee KS, Lee JS, Kim SY, Song CH, Jung SB, Yang 
CS, Jo EK, Park JK, Paik TH, Kim HJ: Mycobacterium tuber-
culosis HBHA protein reacts strongly with the serum im-
munoglobulin  M  of  tuberculosis  patients.  Clin  Vaccine 
Immunol  13;869-875,  2006
16. Baeuerle PA, Henkel T. Function and activation of NF-kap-
pa B in the immune system. Annu Rev Immunol 12;141- 
179,  1994
17. Pathak SK, Bhattacharyya A, Pathak S, Basak C, Mandal D, 
Kundu M, Basu J: Toll-like  receptor 2 and mitogen- and 
stress-activated  kinase  1  are  effectors  of  Mycobacterium 
avium-induced cyclooxygenase-2 expression in macropha-
ges.  J  Biol  Chem  279;55127-55136,  2004
18. Yadav  M,  Roach  SK,  Schorey  JS:  Increased  mi-
togen-activated protein kinase activity and TNF-alpha pro-
duction associated with Mycobacterium smegmatis- but not 
Mycobacterium avium-infected macrophages requires pro-
longed  stimulation  of  the  calmodulin/calmodulin  kinase 
and  cyclic  AMP/protein  kinase  A  pathways.  J  Immunol 
172;5588-5597,  2004
19. Lee HM, Shin DM, Kim KK, Lee JS, Paik TH, Jo EK: Roles 
of reactive oxygen species in CXCL8 and CCL2 expression 
in  response  to  the  30-kDa  antigen  of  Mycobacterium 
tuberculosis.  J  Clin  Immunol  29;46-56,  2009
20. Jung  SB,  Song  CH,  Yang  CS,  Kim  SY,  Lee  KS,  Shin  AR, 
Lee JS, Nam HS, Kim HJ, Park JK, Paik TH, Jo EK: Role 
of the phosphatidylinositol 3-kinase and mitogen-activated 
protein kinase pathways in the secretion of tumor necrosis 
factor-alpha  and  interleukin-10  by  the  PPD  antigen  of 
Mycobacterium  tuberculosis.  J  Clin  Immunol  25;482-490, 
2005
21. Schorey JS, Cooper AM: Macrophage signalling upon myco-
bacterial  infection:  the  MAP  kinases  lead  the  way.  Cell 
Microbiol  5;133-142,  2003
22. Darieva Z, Lasunskaia EB, Campos MN, Kipnis TL, Da Silva 
WD:  Activation  of  phosphatidylinositol  3-kinase  and 
c-Jun-N-terminal kinase cascades enhances NF-kappaB-de-
pendent gene transcription in BCG-stimulated macrophages 
through  promotion  of  p65/p300  binding.  J  Leukoc  Biol 
75;689-697,  2004
23. Sendide K, Reiner NE, Lee JS, Bourgoin S, Talal A, Hmama 
Z:  Cross-talk  between  CD14  and  complement  receptor  3 
promotes  phagocytosis  of  mycobacteria:  regulation  by 
phosphatidylinositol 3-kinase and cytohesin-1. J Immunol 
174;4210-4219,  2005
24. Yang CS, Lee JS, Jung SB, Oh JH, Song CH, Kim HJ, Park 
JK, Paik TH, Jo EK: Differential regulation of interleukin-12 
and  tumour  necrosis  factor-alpha  by  phosphatidylinositol 
3-kinase and ERK 1/2 pathways during Mycobacterium tu-
berculosis infection. Clin Exp Immunol 143;150-160, 2006
2 5 .W e i r  R E ,  B l a c k  G F ,  D o c k r e l l  H M ,  F l o y d  S ,  F i n e  P E ,  
Chaguluka SD, Stenson S, King E, Nazareth B, Warndorff 
DK,  Ngwira  B,  Crampin  AC,  Mwaungulu  L,  Sichali  L, 
Jarman E, Donovan L, Blackwell JM: Mycobacterial purified 
protein  derivatives  stimulate  innate  immunity:  Malawians 
show  enhanced  tumor  necrosis  factor  alpha,  interleukin- 
1beta (IL-1beta), and IL-10 responses compared to those of 
adolescents in the United Kingdom. Infect Immun 72;1807- 
1811,  2004HBHA-induced Inflammatory Signaling
Ki-Hye Kim, et al.
133 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 2 April 2011
26. Wallis RS, Amir-Tahmasseb M, Ellner JJ: Induction of inter-
leukin 1 and tumor necrosis factor by mycobacterial pro-
teins: the monocyte western blot. Proc Natl Acad Sci U S 
A  87;3348-3352,  1990
27. Temmerman  S,  Pethe  K,  Parra  M,  Alonso  S,  Rouanet  C, 
Pickett T, Drowart A, Debrie AS, Delogu G, Menozzi FD, 
Sergheraert C, Brennan MJ, Mascart F, Locht C: Methylation- 
dependent T cell immunity to Mycobacterium tuberculosis 
heparin-binding hemagglutinin. Nat Med 10;935-941, 2004
28. Hougardy  JM,  Schepers  K,  Place  S,  Drowart  A,  Lechevin 
V, Verscheure V, Debrie AS, Doherty TM, Van Vooren JP, 
Locht C, Mascart F: Heparin-binding-hemagglutinin-induced 
IFN-gamma  release  as  a  diagnostic  tool  for  latent  tuber-
culosis.  PLoS  One  2;e926,  2007
2 9 . L o c h t  C ,  H o u g a r d y  J M ,  R o u a n e t  C ,  P l a c e  S ,  M a s c a r t  F :  
Heparin-binding  hemagglutinin,  from  an  extrapulmonary 
dissemination factor to a powerful diagnostic and protective 
antigen against tuberculosis. Tuberculosis (Edinb) 86;303- 
309,  2006
30. Roach DR, Briscoe H, Saunders B, France MP, Riminton S, 
Britton WJ: Secreted lymphotoxin-alpha is essential for the 
control  of  an  intracellular  bacterial  infection.  J  Exp  Med 
193;239-246,  2001
31. Ghosh  S,  Hayden  MS:  New  regulators  of  NF-kappaB  in 
inflammation.  Nat  Rev  Immunol  8;837-848,  2008
32. Wang T, Lafuse WP, Zwilling BS: NFkappaB and Sp1 ele-
ments are necessary for maximal transcription of toll-like 
receptor 2 induced by Mycobacterium avium. J Immunol 
167;6924-6932,  2001
33. Bulut Y, Michelsen KS, Hayrapetian L, Naiki Y, Spallek R, 
Singh M, Arditi M: Mycobacterium tuberculosis heat shock 
proteins use diverse Toll-like receptor pathways to activate 
pro-inflammatory  signals.  J  Biol  Chem  280;20961-20967, 
2005
34. Thoma-Uszynski  S,  Stenger  S,  Takeuchi  O,  Ochoa  MT, 
Engele M, Sieling PA, Barnes PF, Rollinghoff M, Bolcskei 
PL, Wagner M, Akira S, Norgard MV, Belisle JT, Godowski 
PJ, Bloom BR, Modlin RL: Induction of direct antimicrobial 
a c t i v i t y  t h r o u g h  m a m m a l i a n  t o l l - l i k e  r e c e p t o r s .  S c i e n c e  
291;1544-1547,  2001
35. Maiti D, Bhattacharyya A, Basu J: Lipoarabinomannan from 
Mycobacterium tuberculosis promotes macrophage survival 
by  phosphorylating  Bad  through  a  phosphatidylinositol 
3-kinase/Akt  pathway.  J  Biol  Chem  276;329-333,  2001
36. Vanhaesebroeck  B,  Jones  GE,  Allen  WE,  Zicha  D, 
Hooshmand-Rad  R,  Sawyer  C,  Wells  C,  Waterfield  MD, 
Ridley AJ: Distinct PI(3)Ks mediate mitogenic signalling and 
cell migration in macrophages. Nat Cell Biol 1;69-71, 1999
37. Sly LM, Lopez M, Nauseef WM, Reiner NE: 1alpha, 25-Dihy-
droxyvitamin  D3-induced  monocyte  antimycobacterial  ac-
tivity  is  regulated  by  phosphatidylinositol  3-kinase  and 
mediated by the NADPH-dependent phagocyte oxidase. J 
Biol  Chem  276;35482-35493,  2001
38. Lee JS, Son JW, Jung SB, Kwon YM, Yang CS, Oh JH, Song 
CH, Kim HJ, Park JK, Paik TH, Jo EK: Ex vivo responses 
for interferon-gamma and proinflammatory cytokine secre-
tion to low-molecular-weight antigen MTB12 of Mycobacte-
rium  tuberculosis  during  human  tuberculosis.  Scand  J 
Immunol  64;145-154,  2006
39. Song CH, Lee JS, Lee SH, Lim K, Kim HJ, Park JK, Paik 
TH, Jo EK: Role of mitogen-activated protein kinase path-
ways in the production of tumor necrosis factor-alpha, in-
terleukin-10, and monocyte chemotactic protein-1 by Myco-
bacterium tuberculosis H37Rv-infected human monocytes. 
J  Clin  Immunol  23;194-201,  2003
40. Rajaram MV, Ganesan LP, Parsa KV, Butchar JP, Gunn JS, 
Tridandapani  S:  Akt/Protein  kinase  B  modulates  macro-
phage inflammatory response to Francisella infection and 
confers a survival advantage in mice. J Immunol 177;6317- 
6324,  2006
41. Guha  M,  Mackman  N:  The  phosphatidylinositol  3-kin-
ase-Akt pathway limits lipopolysaccharide activation of sig-
naling pathways and expression of inflammatory mediators 
in human monocytic cells. J Biol Chem 277;32124-32132, 
2002
42. Zhang WJ, Wei H, Hagen T, Frei B: Alpha-lipoic acid at-
tenuates LPS-induced inflammatory responses by activating 
the phosphoinositide 3-kinase/Akt signaling pathway. Proc 
Natl  Acad  Sci  U  S  A  104;4077-4082,  2007
43. Hawes  BE,  Luttrell  LM,  van  Biesen  T,  Lefkowitz  RJ: 
Phosphatidylinositol 3-kinase is an early intermediate in the 
G beta gamma-mediated mitogen-activated protein kinase 
signaling  pathway.  J  Biol  Chem  271;12133-12136,  1996
44. Jung ID, Jeong SK, Lee CM, Noh KT, Heo DR, Shin YK, 
Yun  CH,  Koh  WJ,  Akira  S,  Whang  J,  Kim  HJ,  Park  WS, 
Shin SJ, Park YM: Enhanced Efficacy of Therapeutic Cancer 
Vaccines  Produced  by  Co-Treatment  with  Mycobacterium 
tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 
Agonist.  Cancer  Res  71;2858-2870,  2011
45. Place S, Verscheure V, de San N, Hougardy JM, Schepers 
K ,  D i r i x  V ,  D e d i s t e  A ,  M i c h e l  O ,  D r o w a r t  A ,  A l l a r d  S D , 
Doherty TM, Lecher S, Locht C, Mascart F: Heparin-binding, 
hemagglutinin-specific IFN-gamma synthesis at the site of 
infection during active tuberculosis in humans. Am J Respir 
Crit  Care  Med  182;848-854,  2010
46. Zanetti S, Bua A, Delogu G, Pusceddu C, Mura M, Saba 
F ,  P i r i n a  P ,  G a r z e l l i  C ,  V e r tu c c i o  C ,  S e c h i  L A ,  F a d d a  G : 
Patients with pulmonary tuberculosis develop a strong hu-
moral response against methylated heparin-binding hemag-
glutinin.  Clin  Diagn  Lab  Immunol  12;1135-1138,  2005